What is the best adjuvant treatment for very young patients with medulloblastoma? - Wikidata - awgldk - TriplyDB

What is the best adjuvant treatment for very young patients with medulloblastoma?

What is the best adjuvant treatment for very young patients with medulloblastoma?

http://www.wikidata.org/entity/Q36787343

about

Induction chemotherapy and conformal radiation therapy for very young children with nonmetastatic medulloblastoma: Children's Oncology Group study P9934.Treatment of early childhood medulloblastoma by postoperative chemotherapy and deferred radiotherapy.

P2860

Q36212387-B52E4FA4-252D-4DF0-80C6-E3A9B5D0E363 Q37284324-89A647DC-DA9A-4963-B166-FA3B2D47B566

P2860

What is the best adjuvant treatment for very young patients with medulloblastoma?

http://www.wikidata.org/entity/Q36787343

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

2007年论文

@zh

2007年论文

@zh-cn

name

What is the best adjuvant treatment for very young patients with medulloblastoma?

@en

type

label

What is the best adjuvant treatment for very young patients with medulloblastoma?

@en

prefLabel

What is the best adjuvant treatment for very young patients with medulloblastoma?

@en

P1433

Q36787343-BD47E315-87FF-40FC-AAB4-9971044DF030

P1476

Q36787343-5D328C76-E08D-4EA4-93A9-EC578987A530

P2093

Q36787343-01D87FA1-82DB-43BE-B615-FE7E40878961

Q36787343-0C6C71EE-830F-4659-A83B-6A8B2A2B16B4

Q36787343-14C95417-D4B3-4377-9BC3-25A14166D66E

Q36787343-2AF55071-6C7E-47FA-B9B4-7AD0BA63282F

Q36787343-37D9D529-3E20-468F-BB80-54F7FA9239B6

Q36787343-7FE5FAFF-3195-4FB0-B8C0-1A5BCFA568BA

Q36787343-84D80525-18AD-4139-8C08-144AD00DC124

Q36787343-D6961BA4-51DE-4E37-AFBD-7DF019EEAB1D

Q36787343-F8D24274-E1D7-4E3B-BC05-35C5A29C79D1

P2860

Q36787343-068492CD-5361-449F-B758-4435B19CA1A2

Q36787343-0941A0FD-3471-4E82-89F5-3F70260BDD4D

Q36787343-24161920-614E-4FB6-A2F4-BAD5972FD5A5

Q36787343-25746AFF-0FAA-4533-B5AA-C66DC5AD3074

Q36787343-2E8939B1-7F8D-46D9-802E-C3925C307EB5

Q36787343-2F8D7BDA-4468-4713-8AB8-E7A862663DD5

Q36787343-34F7C844-F58B-4024-8F32-7FB96E151287

Q36787343-3594F4B3-F408-4D09-B8CB-625F8C98C6D1

Q36787343-3822DDAF-ECC1-446F-9156-79539C0D74B5

Q36787343-3AE58557-7778-4247-AF14-A723BAD53323

P304

Q36787343-0FBC2421-9866-4CCA-A94D-062CDF74E2F2

P31

Q36787343-CC9A1A40-6ABD-473C-94A6-8BAE88843471

P356

Q36787343-47B6236B-2909-4916-99E2-F77BB76C7301

P433

Q36787343-A0A3B719-179E-4CC1-80A0-76676FC053FA

P478

Q36787343-C8587624-9F32-493B-994B-E5095D4C1467

P577

Q36787343-67476C7C-46B9-4B2E-BAED-B3326E7F8394

P698

Q36787343-23BF45EF-4810-4539-A2B0-DE94BD5DB338

P921

Q36787343-DE2F4FC2-AD11-4A2A-8090-5A6AF324B570

P356

14737175.7.4.373

P1433

Expert Review of Neurotherapeutics: a key contribution to decision making in the treatment of neurologic and neuropsychiatric disorders

P1476

What is the best adjuvant treatment for very young patients with medulloblastoma?

@en

P2093

Arnold C Paulino

http://www.w3.org/2001/XMLSchema#string

Ching C Lau

http://www.w3.org/2001/XMLSchema#string

James W Clarke

http://www.w3.org/2001/XMLSchema#string

John C Grecula

http://www.w3.org/2001/XMLSchema#string

Joseph F Montebello

http://www.w3.org/2001/XMLSchema#string

Katherine Tzou

http://www.w3.org/2001/XMLSchema#string

Mersiha Hadziahmetovic

http://www.w3.org/2001/XMLSchema#string

Nina A Mayr

http://www.w3.org/2001/XMLSchema#string

Simon S Lo

http://www.w3.org/2001/XMLSchema#string

P2860

Identification of human brain tumour initiating cells

Multiagent chemotherapy and deferred radiotherapy in infants with malignant brain tumors: a report from the Children's Cancer Group

beta-Catenin status predicts a favorable outcome in childhood medulloblastoma: the United Kingdom Children's Cancer Study Group Brain Tumour Committee

Notch pathway inhibition depletes stem-like cells and blocks engraftment in embryonal brain tumors.

Medical and neurocognitive late effects among survivors of childhood central nervous system tumors.

Clinical, histopathologic, and molecular markers of prognosis: toward a new disease risk stratification system for medulloblastoma.

Late neurocognitive sequelae in survivors of brain tumours in childhood.

The therapy of infantile malignant brain tumors: current status?

Molecular biology of medulloblastoma: will it ever make a difference to clinical management?

Feasibility and response to induction chemotherapy intensified with high-dose methotrexate for young children with newly diagnosed high-risk disseminated medulloblastoma.

P304

373-381

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1586/14737175.7.4.373

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P577

2007-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

17425492

http://www.w3.org/2001/XMLSchema#string

P921

medulloblastoma